Last reviewed · How we verify
NCT04665440: OXYVOICE
Response of Preterm Infants to Multisensory Stimuli
NA trial testing Voice alone in Mother-Infant Interaction in 28 participants. Terminated before completion.
3 November 2022
Quick facts
| Lead sponsor | University Hospital, Geneva |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 28 |
| Start date | 1 September 2020 |
| Primary completion | 3 November 2022 |
| Estimated completion | 3 November 2022 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Voice alone
- Voice + tactile stimuli
Conditions studied
- Mother-Infant Interaction — all drugs for Mother-Infant Interaction →
Sponsor
University Hospital, Geneva
Who can join
Adults 32 Weeks to 35 Weeks, any sex, with Mother-Infant Interaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to measure the variation of oxytocin and cortisol levels in the saliva of premature neonates and their mother after sensorial stimuli.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Maternal Voice and Tactile Stimulation Modulate Oxytocin in Mothers of Hospitalized Preterm Infants: A Randomized Crossover Trial.
Hirschel J, Carlhan-Ledermann A, Ferraz C, Brand LA, et al · · 2023 · cited 6× · PMID 37761430 · DOI 10.3390/children10091469
Verify or expand the search:
- PubMed search for NCT04665440
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mother-Infant Interaction
Currently open trials in the same condition.
- NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting
- NCT05861531 — Combined Oral Motor Stimulation and Language on Preterm Infant Feeding · NA · recruiting
- NCT04531618 — Mother-infant Bonding During COVID-19 · NA · active not recruiting
- NCT06234332 — Peking University Birth Cohort in Weifang (PKUBC-WF) · recruiting
- NCT05975203 — Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants · NA · recruiting
Other University Hospital, Geneva trials
Trials by the same sponsor.
- NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
- NCT07267624 — EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) · NA · not yet recruiting
- NCT06710210 — Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventi · NA · not yet recruiting
- NCT07173348 — Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea · NA · not yet recruiting
- NCT07129655 — Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Ch · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04665440 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Geneva
- Last refreshed: 10 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04665440.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing